You are here
Overview of permitted indications and transition arrangements
This online training resource provides an overview of permitted indications and the transition arrangements for medicines listed before 6 March 2018.
The module also provides links to resources that may assist sponsors in meeting the requirements for listed medicines.
This module takes approximately 10 minutes to complete.
Please note: We are in the process of updating this module. In the meantime, page 9 requires the following date corrections:
- The transition period for permitted indications ends on 5 March 2021.
- Changes to permitted indications can be done free of charge until 5 March 2021.
- ARTG entries that have not transitioned to Permitted Indications will be cancelled on 6 March 2021.